日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia

复发性婴幼儿KMT2A重排急性白血病的基因组图谱

Louise Ahlgren,Mattias Pilheden,Helena Sturesson,Guangchun Song,Michael P Walsh,Minjun Yang,Maud Maillard,Huanbin Zhao,Zhongshan Cheng,Varsha Singh,Anders Castor,Cornelis Jan Pronk,Hanne Vibeke Marquart,Birgitte Lausen,Pauline Schneider,Gisela Barbany,Katja Pokrovskaja Tamm,Jonas Abrahamsson,Olli Lohi,Linda Fogelstrand,Pablo Menendez,Rob Pieters,Jinghui Zhang,Karin Lindkvist-Petersson,Jun J Yang,Tanja A Gruber,Ronald W Stam,Jing Ma,Anna K Hagström-Andersson

Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia

选择性抑制 HDAC IIA 类作为 KMT2A 重排急性淋巴细胞白血病的治疗干预措施

Tamara C A I Verbeek ,Kirsten S Vrenken ,Susan T C J M Arentsen-Peters ,Patricia Garrido Castro ,Marieke van de Ven ,Olaf van Tellingen ,Rob Pieters ,Ronald W Stam

Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic and Myeloid Leukemia

KMT2A重排急性淋巴细胞白血病和髓系白血病对Menin抑制剂的不同反应及其与DOT1L抑制剂的协同作用

Fabienne R S Adriaanse ,Pauline Schneider ,Susan T C J M Arentsen-Peters ,Ana M Neves da Fonseca ,Janine Stutterheim ,Rob Pieters ,C Michel Zwaan ,Ronald W Stam

STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL2 and BCLXL following glucocorticoid treatment

尽管糖皮质激素治疗后 BCL2 和 BCLXL 被激活,但 STAT5 并不会导致 T 细胞急性淋巴细胞白血病产生类固醇耐药性

Jordy C G Van der Zwet, Valentina Cordo', Jessica G C A M Buijs-Gladdines, Rico Hagelaar, Willem K Smits, Eric Vroegindeweij, Laura T M Graus, Vera Poort, Marloes Nulle, Rob Pieters, Jules P P Meijerink

CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia

CRISPR-Cas9文库筛选鉴定出KMT2A重排急性淋巴细胞白血病中的新型分子脆弱性

Pauline Schneider ,Priscilla Wander ,Susan T C J M Arentsen-Peters ,Kirsten S Vrenken ,Dedeke Rockx-Brouwer ,Fabienne R S Adriaanse ,Veerle Hoeve ,Irene Paassen ,Jarno Drost ,Rob Pieters ,Ronald W Stam

Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia

SARC-F 评分的新改进,用于对患有功能性肌肉减少症的儿童血液肿瘤患者进行分类

Emma J Verwaaijen, Patrick van der Torre, Josef Vormoor, Rob Pieters, Marta Fiocco, Annelies Hartman, Marry M van den Heuvel-Eibrink

Identification and characterization of relapse-initiating cells in MLL-rearranged infant ALL by single-cell transcriptomics

通过单细胞转录组学鉴定和表征 MLL 重排婴儿 ALL 中的复发起始细胞

Tito Candelli #, Pauline Schneider #, Patricia Garrido Castro, Luke A Jones, Eduard Bodewes, Dedeke Rockx-Brouwer, Rob Pieters, Frank C P Holstege, Thanasis Margaritis, Ronald W Stam

MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus

MEF2C 在淋巴细胞谱系决定中与 Notch 信号通路拮抗,并驱动胸腺中的白血病发生。

Kirsten Canté-Barrett ,Mariska T Meijer ,Valentina Cordo' ,Rico Hagelaar ,Wentao Yang ,Jiyang Yu ,Willem K Smits ,Marloes E Nulle ,Joris P Jansen ,Rob Pieters ,Jun J Yang ,Jody J Haigh ,Steven Goossens ,Jules Pp Meijerink

High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling

在原发性 KMT2A 重排婴儿 ALL 细胞中进行高通量药物库筛选有利于鉴定激活 P53 信号传导的候选药物

Priscilla Wander, Susan T C J M Arentsen-Peters, Kirsten S Vrenken, Sandra Mimoso Pinhanҫos, Bianca Koopmans, M Emmy M Dolman, Luke Jones, Patricia Garrido Castro, Pauline Schneider, Mark Kerstjens, Jan J Molenaar, Rob Pieters, Christian Michel Zwaan, Ronald W Stam

MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance

MAPK-ERK 是 T 细胞急性淋巴细胞白血病中的一条中心通路,可驱动类固醇耐药性

Jordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', Donna O Debets, Willem K Smits, Zhongli Chen, Jelle Dylus, Guido J R Zaman, Maarten Altelaar, Koichi Oshima, Beat Bornhauser, Jean-Pierre Bourquin, Jan Cools, Adolfo A Ferrando, Josef Vormoor, Rob Pieters, Britta Vormoor, Jul